Castle Biosciences, Inc. (CSTL) Free Cash Flow
Castle Biosciences, Inc. (CSTL) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2019-12-31 | $6.08M |
| 2020-12-31 | $5.12M |
| 2021-12-31 | -$22.47M |
| 2022-12-31 | -$47.29M |
| 2023-12-31 | -$19.25M |
| 2024-12-31 | $36.54M |
| 2025-12-31 | $28.33M |
How CSTL compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ARRY | Array Technologies Inc. | $79.81M |
| AKBA | Akebia Therapeutics Inc. | $67.70M |
| TGTX | TG Therapeutics Inc. | -$24.99M |
| MYGN | Myriad Genetics Inc. | -$25.60M |
| TRVI | Trevi Therapeutics Inc. | -$42.10M |
These are five companies in the same sector as CSTL with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Castle Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("CSTL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CSTL | $34.12 | -0.23% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |